Source: Journal of the American College of Cardiology. Conference titles: Annual Scientific Session and Expo (ACC). Unidade: FM
Subjects: DOENÇA DE CHAGAS, FÁRMACOS (SISTEMA CARDIOVASCULAR), INSUFICIÊNCIA CARDÍACA
ABNT
BOCCHI, Edimar Alcides e GUIMARÃES, Guilherme. Efficacy and safety profile of ivabradine in heart faillue due to Chagas’ heart disease: a post-hoc analysis of the Shift trial. Journal of the American College of Cardiology. New York: Elsevier. Disponível em: https://doi.org/10.1016/S0735-1097(17)34311-5. Acesso em: 23 maio 2024. , 2017APA
Bocchi, E. A., & Guimarães, G. (2017). Efficacy and safety profile of ivabradine in heart faillue due to Chagas’ heart disease: a post-hoc analysis of the Shift trial. Journal of the American College of Cardiology. New York: Elsevier. doi:10.1016/S0735-1097(17)34311-5NLM
Bocchi EA, Guimarães G. Efficacy and safety profile of ivabradine in heart faillue due to Chagas’ heart disease: a post-hoc analysis of the Shift trial [Internet]. Journal of the American College of Cardiology. 2017 ; 69 922.[citado 2024 maio 23 ] Available from: https://doi.org/10.1016/S0735-1097(17)34311-5Vancouver
Bocchi EA, Guimarães G. Efficacy and safety profile of ivabradine in heart faillue due to Chagas’ heart disease: a post-hoc analysis of the Shift trial [Internet]. Journal of the American College of Cardiology. 2017 ; 69 922.[citado 2024 maio 23 ] Available from: https://doi.org/10.1016/S0735-1097(17)34311-5